In 2025, the Xtalks Life Science Podcast featured conversations with industry leaders across pharma, biotech, medtech and healthcare, highlighting innovations in areas from neurodegenerative diseases and oncology to autoimmune diseases and ocular diseases, as well as technologies such as AI-enabled drug discovery, cell and gene therapies and digital health tools. Looking ahead to 2026, expect more informative conversations around themes shaping drug development, clinical trials, regulation and commercialization.
Read more at prnewswire.com
Nasdaq
華爾街日報